ESR1 and breast cancer: They tested dihydroresveratrol on the breast cancer cell lines MCF-7 (estrogen receptor positive) and MDA-MB-231 (estrogen receptor negative) to determine whether there is a decrease in cell proliferation following exposure to polyphenols.